Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

EBR:SYENS - Euronext Brussels - BE0974464977 - Common Stock - Currency: EUR

77.46  +0.6 (+0.78%)

Fundamental Rating

3

Taking everything into account, SYENS scores 3 out of 10 in our fundamental rating. SYENS was compared to 60 industry peers in the Chemicals industry. SYENS has an average financial health and profitability rating. SYENS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SYENS was profitable.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

SYENS has a Return On Assets (0.17%) which is comparable to the rest of the industry.
SYENS's Return On Equity of 0.29% is in line compared to the rest of the industry. SYENS outperforms 43.86% of its industry peers.
SYENS's Return On Invested Capital of 4.82% is fine compared to the rest of the industry. SYENS outperforms 61.40% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SYENS is above the industry average of 6.58%.
The 3 year average ROIC (9.21%) for SYENS is well above the current ROIC(4.82%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.17%
ROE 0.29%
ROIC 4.82%
ROA(3y)3.99%
ROA(5y)N/A
ROE(3y)10.71%
ROE(5y)N/A
ROIC(3y)9.21%
ROIC(5y)N/A
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40

1.3 Margins

SYENS's Profit Margin of 0.25% is in line compared to the rest of the industry. SYENS outperforms 43.86% of its industry peers.
SYENS has a better Operating Margin (7.78%) than 66.67% of its industry peers.
SYENS's Operating Margin has improved in the last couple of years.
SYENS's Gross Margin of 33.27% is in line compared to the rest of the industry. SYENS outperforms 52.63% of its industry peers.
In the last couple of years the Gross Margin of SYENS has grown nicely.
Industry RankSector Rank
OM 7.78%
PM (TTM) 0.25%
GM 33.27%
OM growth 3Y22.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.06%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SYENS is creating some value.
Compared to 1 year ago, SYENS has less shares outstanding
The debt/assets ratio for SYENS has been reduced compared to a year ago.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

SYENS has an Altman-Z score of 2.61. This is not the best score and indicates that SYENS is in the grey zone with still only limited risk for bankruptcy at the moment.
SYENS has a better Altman-Z score (2.61) than 64.91% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that SYENS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.24, SYENS is doing good in the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 2.61
ROIC/WACC0.78
WACC6.21%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2B 4B 6B

2.3 Liquidity

SYENS has a Current Ratio of 1.76. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
SYENS has a Current ratio (1.76) which is comparable to the rest of the industry.
A Quick Ratio of 1.08 indicates that SYENS should not have too much problems paying its short term obligations.
The Quick ratio of SYENS (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.08
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -79.77% in the last year.
Looking at the last year, SYENS shows a very negative growth in Revenue. The Revenue has decreased by -13.02% in the last year.
The Revenue has been growing by 9.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-79.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-13.02%
Revenue growth 3Y9.5%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

SYENS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.38% yearly.
The Revenue is expected to grow by 3.05% on average over the next years.
EPS Next Y-27.01%
EPS Next 2Y-6.52%
EPS Next 3Y0.21%
EPS Next 5Y5.38%
Revenue Next Year-4.63%
Revenue Next 2Y-0.35%
Revenue Next 3Y1.61%
Revenue Next 5Y3.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SYENS is valuated quite expensively with a Price/Earnings ratio of 387.30.
Compared to the rest of the industry, the Price/Earnings ratio of SYENS indicates a slightly more expensive valuation: SYENS is more expensive than 63.16% of the companies listed in the same industry.
SYENS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.47.
Based on the Price/Forward Earnings ratio of 11.82, the valuation of SYENS can be described as reasonable.
Based on the Price/Forward Earnings ratio, SYENS is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 92.74. SYENS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 387.3
Fwd PE 11.82
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYENS is valued a bit cheaper than 71.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.8
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.52%
EPS Next 3Y0.21%

More info and screens

1

5. Dividend

5.1 Amount

SYENS has a Yearly Dividend Yield of 1.47%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.94, SYENS has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.28, SYENS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 0.5 1 1.5

5.3 Sustainability

SYENS pays out 2809.52% of its income as dividend. This is not a sustainable payout ratio.
DP2809.52%
EPS Next 2Y-6.52%
EPS Next 3Y0.21%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 500M -500M -1B
SYENS.BR Dividend Payout.SYENS.BR Dividend Payout, showing the Payout Ratio.SYENS.BR Dividend Payout.PayoutRetained Earnings

More info and screens

SYENSQO SA

EBR:SYENS (2/5/2025, 9:34:06 AM)

77.46

+0.6 (+0.78%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-27 2025-02-27
Inst Owners26.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.20B
Analysts79.29
Price Target96.11 (24.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend4.13
Dividend Growth(5Y)N/A
DP2809.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.67%
Min EPS beat(2)-12.42%
Max EPS beat(2)-6.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.61%
PT rev (3m)-1.31%
EPS NQ rev (1m)-4.04%
EPS NQ rev (3m)-15.65%
EPS NY rev (1m)-8.65%
EPS NY rev (3m)-11.06%
Revenue NQ rev (1m)-0.43%
Revenue NQ rev (3m)-9.32%
Revenue NY rev (1m)-0.79%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 387.3
Fwd PE 11.82
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 2.54
EV/EBITDA 6.8
EPS(TTM)0.2
EY0.26%
EPS(NY)6.55
Fwd EY8.46%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS79.87
BVpS69.42
TBVpS30.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.17%
ROE 0.29%
ROCE 6.41%
ROIC 4.82%
ROICexc 5.18%
ROICexgc 9.1%
OM 7.78%
PM (TTM) 0.25%
GM 33.27%
FCFM N/A
ROA(3y)3.99%
ROA(5y)N/A
ROE(3y)10.71%
ROE(5y)N/A
ROIC(3y)9.21%
ROIC(5y)N/A
ROICexc(3y)9.76%
ROICexc(5y)N/A
ROICexgc(3y)22.15%
ROICexgc(5y)N/A
ROCE(3y)12.24%
ROCE(5y)N/A
ROICexcg growth 3Y-6.34%
ROICexcg growth 5YN/A
ROICexc growth 3Y15.33%
ROICexc growth 5YN/A
OM growth 3Y22.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.06%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.08
Altman-Z 2.61
F-ScoreN/A
WACC6.21%
ROIC/WACC0.78
Cap/Depr(3y)92.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.66%
Cap/Sales(5y)N/A
Profit Quality(3y)120.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-27.01%
EPS Next 2Y-6.52%
EPS Next 3Y0.21%
EPS Next 5Y5.38%
Revenue 1Y (TTM)-13.02%
Revenue growth 3Y9.5%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-4.63%
Revenue Next 2Y-0.35%
Revenue Next 3Y1.61%
Revenue Next 5Y3.05%
EBIT growth 1Y-16.1%
EBIT growth 3Y33.84%
EBIT growth 5YN/A
EBIT Next Year36.01%
EBIT Next 3Y17.1%
EBIT Next 5Y12.82%
FCF growth 1Y-42.95%
FCF growth 3Y-18.15%
FCF growth 5YN/A
OCF growth 1Y-4.57%
OCF growth 3Y5.3%
OCF growth 5YN/A